NCT06556927 The Laughter, Pregnancy, Anxiety and Llife Quality
| NCT ID | NCT06556927 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kırklareli University |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2025-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-10-01 with a primary completion date of 2025-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Gestational Diabetes is one of the most common medical complications during pregnancy. It is seen between the 24th and 28th weeks of pregnancy with the increase in insulin resistance in the second trimester and ends with the end of the birth process. Due to this feature, it is distinguished from Type 2 diabetes. This disease, which is seen for the necessary energy needs of the fetus and placenta, is defined as the diabetogenic effect of pregnancy. Laughter is a universal response to humorous stimuli that exists in our lives. Laughter yoga is holistic with breathing techniques. It is a form of yoga that utilizes the brain's inability to distinguish between real and fake laughter. Laughter yoga helps people cope with stressful times and helps the person control themselves by reducing negative cognitive reactions. In line with this information, the aim of the study was to determine the effect of laughter yoga applied to pregnant women with gestational diabetes on perceived stress and quality of life.
Eligibility Criteria
Inclusion Criteria: * Volunteering to participate in the study * Answering the survey and scale forms completely * Being 18 years of age or older * Being able to read and understand Turkish * Not having any physical or mental problems that would prevent communication * Pregnant women diagnosed with gestational diabetes * Being in social media accounts and WhatsApp groups * Scoring 35 and above on the STAI scale * Scoring 37 and above on the quality of life scale during pregnancy Exclusion Criteria: * Not volunteering to participate in the study * Incomplete responses to surveys and scales * Being under the age of 18 * Not understanding Turkish * Having any physical or mental problems that would prevent communication * Pregnant women who have not been diagnosed with gestational diabetes
Contact & Investigator
AYCA SOLT KIRCA, Phd
STUDY CHAIR
Kırklareli University
Frequently Asked Questions
Who can join the NCT06556927 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 35 Years, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06556927 currently recruiting?
Yes, NCT06556927 is actively recruiting participants. Contact the research team at remziyekaradogankosanoglu@gmail.com for enrollment information.
Where is the NCT06556927 trial being conducted?
This trial is being conducted at Kırklareli, Turkey (Türkiye).
Who is sponsoring the NCT06556927 clinical trial?
NCT06556927 is sponsored by Kırklareli University. The principal investigator is AYCA SOLT KIRCA, Phd at Kırklareli University. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.